TGTX earnings
TG Therapeutics (TGTX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- TGTX beat EPS estimates in 5 of its last 13 reports.
TGTX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 9, 2026 | 0.35 | 0.36 | -2.59% | $259.94M |
| Q2 2026 | Aug 3, 2026 | 0.05 | 0.31 | -83.64% | $240.34M |
| Q1 2026 | May 6, 2026 | 0.14 | 0.23 | -39.13% | $204.92M |
| Q4 2025 | Feb 26, 2026 | 0.14 | 0.35 | -60.00% | $192.57M |
| Q3 2025 | Nov 3, 2025 | 2.43 | 0.24 | 912.50% | $161.71M |
| Q2 2025 | Aug 4, 2025 | 0.17 | 0.32 | -46.88% | $141.15M |
| Q1 2025 | May 5, 2025 | 0.03 | 0.18 | -83.33% | $120.86M |
| Q4 2024 | Mar 3, 2025 | 0.15 | 0.08 | 87.50% | $108.19M |
| Q3 2024 | Nov 4, 2024 | 0.02 | 0.03 | -33.33% | $83.88M |
| Q2 2024 | Aug 6, 2024 | 0.04 | -0.05 | 180.00% | $73.47M |
| Q1 2024 | May 1, 2024 | -0.07 | -0.04 | -96.02% | $63.47M |
| Q4 2023 | Feb 28, 2024 | -0.09 | -0.12 | 25.00% | $43.97M |
| Q3 2023 | Nov 1, 2023 | 0.73 | – | – | $165.81M |
| Q2 2023 | Aug 1, 2023 | -0.34 | – | – | $16.07M |
| Q1 2023 | May 1, 2023 | -0.28 | -0.36 | 22.22% | $7.80M |
| Q4 2022 | Feb 28, 2023 | -0.39 | – | – | $81.00K |
| Q3 2022 | Nov 10, 2022 | -0.26 | – | – | $94.00K |